COPD Management Guidelines

Assessment and Classification

Spirometric testing is preferred to peak expiratory flow recordings for diagnosis and assessment of COPD severity, as recommended by the British Thoracic Society 2
A positive spirometric response to bronchodilators or corticosteroids is considered present when lung function increases by 200 ml and 15% of baseline value, according to the British Thoracic Society 2
Estimation of arterial blood gas tensions is necessary in severe COPD to identify persistent low oxygen levels with or without high carbon dioxide levels, as stated by the British Thoracic Society 2

The American College of Chest Physicians recommends that patients with mild COPD and no symptoms require no drug treatment 1
For symptomatic patients with mild COPD, the British Thoracic Society suggests using short-acting bronchodilators as needed, such as short-acting β2 agonist or short-acting inhaled anticholinergic 3, 1
The British Thoracic Society recommends regular bronchodilator therapy for moderate COPD, including long-acting muscarinic antagonists for exacerbation prevention 1, 3
Combination therapy is recommended for severe COPD, including regular β2 agonist and anticholinergic, as well as consideration of LABA/LAMA combinations for optimal bronchodilation, according to the American College of Chest Physicians 3, 2, 1

The British Thoracic Society emphasizes that smoking cessation is essential at all stages of COPD and is the single most important intervention 3, 1
Participation in active smoking cessation programs leads to higher sustained quit rates, especially with nicotine replacement therapy, as recommended by the British Thoracic Society 3
The British Thoracic Society suggests that exercise should be encouraged where possible, and pulmonary rehabilitation programs improve exercise performance and reduce breathlessness in moderate to severe disease 3, 1
Annual influenza vaccination is recommended, especially for moderate to severe disease, according to the British Thoracic Society 3, 1

The British Thoracic Society states that long-term oxygen therapy prolongs life in patients with low oxygen levels 3
Long-term oxygen therapy should only be prescribed with objectively demonstrated low oxygen levels, as recommended by the British Thoracic Society 3
The American College of Chest Physicians suggests considering pulmonary rehabilitation for patients with moderate to severe disease 1
Surgery may be indicated for recurrent lung collapses and isolated bullous disease, according to the British Thoracic Society 3
Lung volume reduction surgery may be useful in selected patients, as stated by the British Thoracic Society 3

The British Thoracic Society recommends avoiding beta-blocking agents in COPD patients 4
There is no evidence supporting prophylactic antibiotics given continuously or intermittently, according to the British Thoracic Society 4
The British Thoracic Society states that certain medications have limited value in routine COPD management, such as theophyllines 3
Regularly assess inhaler technique as errors are common and can significantly impact treatment efficacy, as recommended by the British Thoracic Society and the American College of Chest Physicians 4, 1